• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

ObjectiveHealth Secures Growth Investment to Expand Innovative Clinical Research Model

by Fred Pennic 01/29/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
What You Should Know:

ObjectiveHealth, a pioneer in integrated specialty research, today announced a strategic investment from Vitruvian Partners, a renowned global growth equity firm.

– This strategic investment will fuel ObjectiveHealth’s expansion and its mission to revolutionize clinical research by seamlessly integrating trials into the practices of community-based physicians.

Transforming Clinical Trials, One Patient at a Time:

ObjectiveHealth stands out with its innovative approach. They act as a bridge between pharmaceutical companies and patients, seamlessly integrating clinical trials into the existing workflows of specialty physicians. This is achieved through:

  • Proprietary AI technology: Leveraging patient electronic health record data and physician schedules, ObjectiveHealth’s AI efficiently identifies potential trial candidates, saving time and resources.
  • Streamlined trial management: Their platform simplifies trial workflow, providing physicians with tools to manage the process effectively.
  • Dedicated research coordinators: On-site coordinators ensure smooth trial execution and support both patients and physicians.
  • Community-based centers-of-excellence: By embedding trials within existing practices, ObjectiveHealth creates centers of excellence in specialty care, benefiting both patients and the research community.

Vitruvian Partners Fuels Growth:

Vitruvian’s investment recognizes ObjectiveHealth’s potential to disrupt the clinical research landscape. This funding will enable the company to:

  • Expand its network of partner practices: Reach a wider pool of patients and drive greater participation in vital clinical trials.
  • Further develop its AI technology: Enhance patient matching capabilities and streamline trial management processes.
  • Invest in research infrastructure: Strengthen its capabilities to conduct high-quality clinical research across diverse specialties.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A: Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |